University City-based FORE Biotherapeutics raised $75 million in a Series D round, the biotech company announced today. The round was led by SR One and Medicxi. This funding will be used to further ...
People watching The Masters have no doubt noticed the announcer on the first tee at Augusta National Golf Club saying “fore please.” Some people might not think anything of it, but it's undeniably ...
FORE Real logo · GlobeNewswire Inc. LOS ANGELES, May 14, 2026 (GLOBE NEWSWIRE) -- FORE Enterprise, a leading AI Solutions architect, is launching early access to FORE Real, the first AI property ...
LOS ANGELES, July 17, 2025 (GLOBE NEWSWIRE) -- FORE Enterprise, a premier AI solutions architect, is expanding its focus and tripling the size of its team to help companies across industries – ...
PHILADELPHIA--(BUSINESS WIRE)--FORE Biotherapeutics, a registration stage biotherapeutics company dedicated to developing targeted therapies to treat patients with cancer, today presented new ...
PHILADELPHIA--(BUSINESS WIRE)--Fore Biotherapeutics (Fore Bio), a precision oncology company dedicated to developing innovative treatments that provide a better outcome for cancer patients, today ...
Fore Enterprise chief executive Tyler Hochman. Fore Enterprise is emerging from stealth with a previously unannounced cache of seed funding. The Brentwood-based data analytics company uses artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results